Anlong
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Anlong - overview
Established
2016
Location
Hefei, Anhui, China
Primary Industry
Biotechnology
About
Based in Hefei, China and established in 2016, Anlong is a biopharmaceutical company which focuses on reaching and developing gene sequencing technology. It also develops and manufactures in vitro diagnostic products.
Current Investors
Zhongan Luyang Venture Capital Fund
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy
Website
www.anlongen.com
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Anlong - key contacts
| Name | Position | Start Date | End Date | Vcard | Bio | ||
|---|---|---|---|---|---|---|---|
| Chief Executive Officer & General Manager | BM |
BM Board Member
Want to see more?
Request a demo for full access to this profile
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.